IMMUNOPHENOTYPE OF SOLID TUMORS AND TUMOR METABOLIC REPROGRAMMING

Date
2024
Authors
zitello, emory david
Contributor
Advisor
Bingham, Jon-Paul
Department
Molecular Biosciences and Bioengineering
Instructor
Depositor
Speaker
Researcher
Consultant
Interviewer
Annotator
Journal Title
Journal ISSN
Volume Title
Publisher
Volume
Number/Issue
Starting Page
Ending Page
Alternative Title
Abstract
ABSTRACTWith the technological advances in biotechnology that have been made high-throughput measurement of nucleic acids feasible and affordable, the tumor microenvironment (TME) has been intensively studied. Advances in therapy have made pharmacologic treatment of cancer more effective than ever before. However, in consideration of the expense of the new class of monoclonal immunotherapeutic antibodies, their occasionally serious side effect profile, and a somewhat limited spectrum of activity among patient cohorts, there has come a great demand to understand the factors which make individual cases of cancer differ. Many approaches to address the issue of individual patient response to immunomodulatory antibodies have been devised. Both traditional, bench-based approaches and more modern, bioinformatical solutions have yielded important insights into the problem. Unfortunately, many difficult and important questions have remained unexplained. In particular, a general theory that is capable of explaining the broadest similarity of observed clinical responses to therapy with monoclonal immunotherapeutic agents across dissimilar patient cohorts that identifies a clear relationship to cellular and molecular features has been elusive. Understanding the most important concepts involved in tumor immunology requires drawing together some intermediate and detailed knowledge from several subdisciplines in biology and clinical medicine. In the studies presented here, elements of bioinformatic data analysis, details of immunological function, and knowledge of cellular and molecular processes relevant to cancer are reviewed in terms of published literature as an introduction. In a second segment, these topics of perceived relevance to studies of cancer are then highlighted with presentations of new findings based upon a novel bioinformatic approach. A summary is presented in Chapter 3 containing a brief discussion of how these findings impact the field with reference to current knowledge and practice, while a series of Appendices further substantiate the importance of these findings with brief details of a variety of related results.
Description
Keywords
Medicine, Immunology, Bioinformatics, bioinformatics, biologic therapies, immunophenotype, molecular diagnostics, pan-cancer, tumor immunology
Citation
Extent
201 pages
Format
Geographic Location
Time Period
Related To
Table of Contents
Rights
All UHM dissertations and theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission from the copyright owner.
Rights Holder
Local Contexts
Email libraryada-l@lists.hawaii.edu if you need this content in ADA-compliant format.